Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission tomography imaging

Mo, Y., Stromswold, J., Wilson, K., Holder, D., Sur, C., Laterza, O., Savage, M.J., Struyk, A., Scheltens, P., Teunissen, C.E., Burke, J., Macaulay, S.L., Bråthen, G., Sando, S.B., White, L.R., Weiss, C., Cowes, A., Bush, M.M., DeSilva, G., Darby, D.G., Rainey‐Smith, S.R., Surls, J., Sagini, E., Tanen, M., Altman, A., Luthman, J. and Egan, M.F. (2017) A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission tomography imaging. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 6 (1). pp. 201-209.

[img]
Preview
PDF - Published Version
Download (537kB) | Preview
Free to read: https://doi.org/10.1016/j.dadm.2017.02.004
*No subscription required

Abstract

Introduction

Changes in cerebrospinal fluid (CSF) tau and amyloid β (Aβ)42 accompany development of Alzheimer's brain pathology. Robust tau and Aβ42 immunoassays were developed to establish a tau/Aβ42 cutoff distinguishing mild‐to‐moderate Alzheimer's disease (AD) subjects from healthy elderly control (HC) subjects.

Methods

A CSF tau/Aβ42 cutoff criteria was chosen, which distinguished the groups and maximized concordance with amyloid PET. Performance was assessed using an independent validation cohort.

Results

A tau/Aβ42 = 0.215 cutoff provided 94.8% sensitivity and 77.7% specificity. Concordance with PET visual reads was estimated at 86.9% in a ∼50% PET positive population. In the validation cohort, the cutoff demonstrated 78.4% sensitivity and 84.9% specificity to distinguish the AD and HC populations.

Discussion

A tau/Aβ42 cutoff with acceptable sensitivity and specificity distinguished HC from mild‐to‐moderate AD subjects and maximized concordance to brain amyloidosis. The defined cutoff demonstrated that CSF analysis may be useful as a surrogate to imaging assessment of AD pathology.

Item Type: Journal Article
Publisher: Elsevier Inc. on behalf of the Alzheimer’s Association
Copyright: © 2017 The Authors.
URI: http://researchrepository.murdoch.edu.au/id/eprint/60786
Item Control Page Item Control Page

Downloads

Downloads per month over past year